UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053317
Receipt number R000060857
Scientific Title A phase II study to evaluate the safety of first-time radical gastrectomy by robotic approach for stomach cancer in an early stage
Date of disclosure of the study information 2024/01/10
Last modified on 2024/01/10 23:04:04

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A phase II study to evaluate the safety of first-time radical gastrectomy by robotic approach for stomach cancer in an early stage

Acronym

ERSTE-M study

Scientific Title

A phase II study to evaluate the safety of first-time radical gastrectomy by robotic approach for stomach cancer in an early stage

Scientific Title:Acronym

ERSTE-M study

Region

Japan


Condition

Condition

Gastric cancer

Classification by specialty

Gastrointestinal surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the safety of robotic distal gastrectomy (RDG) with lymph node dissection performed by surgeons with limited experience in gastric cancer surgery

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Incidence of intra-abdominal infectious complications after gastrectomy

Key secondary outcomes

1. overall survival, 2. relapse-free survival, 3. completion rate of robotic surgeries, 4. incidence of adverse events


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver

Interventions/Control_1

Robotic distal gastrectomy (RDG) with lymph node dissection of D1+ or higher, performed under proctor guidance via dual console by surgeons with limited experience performing gastric cancer surgery

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Histologically proven gastric adenocarcinoma by endoscopic biopsy.
2) The diagnosis of clinical T1N0.
3) Not indicated for ESD.
4) Distal or total gastrectomy is required for radical resection, and R0 surgery is feasible.
5) No invasion to duodenum.
6) Aged 20 years old or older.
7) Eastern Cooperative Oncology Group performance status of 0 or 1.
8) Body mass index (BMI) is less than 30.
9) No history of upper abdominal surgery except laparoscopic cholecystectomy.
10) No prior chemotherapy, endocrine therapy and/or radiotherapy for any malignancies.
11) Adequate organ functions defined as;
i) WBC of 3,000/mm3 or more
ii) Platelet count 100,000/mm3 or more
iii) AST and/or ALT of 100 IU/L or less
iv) T.Bil of 2.0 mg/dL or less
v) Creatinine of 1.5 mg/dL or less
12) Written informed consent.

Key exclusion criteria

1) Synchronous or metachronous (within 5 years) malignancies.
2) During pregnancy, within 28 days postpartum, or during lactation.
3) Severe mental disease.
4) Receiving continuous systemic corticosteroid or immunosuppressant treatment.
5) History of unstable angina pectoris within three weeks or myocardial infarction within six months before registration.
6) Poorly controlled hypertension.
7) Uncontrolled diabetes mellitus.
8) Respiratory disease requiring continuous oxygen administration.

Target sample size

22


Research contact person

Name of lead principal investigator

1st name Makoto
Middle name
Last name Hikage

Organization

Iwate Prefectural Isawa Hospital

Division name

Division of Surgery

Zip code

023-0864

Address

61 Ryugababa, Mizusawa-ku, Oshu-shi, Iwate, Japan

TEL

0197-24-4121

Email

mhikage@med.tohoku.ac.jp


Public contact

Name of contact person

1st name Makoto
Middle name
Last name Hikage

Organization

Iwate Prefectural Isawa Hospital

Division name

Division of Surgery

Zip code

023-0864

Address

61 Ryugababa, Mizusawa-ku, Oshu-shi, Iwate, Japan

TEL

0197-24-4121

Homepage URL


Email

mhikage@med.tohoku.ac.jp


Sponsor or person

Institute

Iwate Prefectural Isawa Hospital

Institute

Department

Personal name



Funding Source

Organization

self-funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Iwate Prefectural Isawa Hospital Institutional Review Board

Address

61 Ryugababa, Mizusawa-ku, Oshu-shi, Iwate, Japan

Tel

0197-24-4121

Email

isawasenmoni@gmail.com


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 10 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2023 Year 08 Month 10 Day

Date of IRB

2023 Year 08 Month 16 Day

Anticipated trial start date

2024 Year 01 Month 10 Day

Last follow-up date

2031 Year 07 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 10 Day

Last modified on

2024 Year 01 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060857